The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Former FDA Commissioner Joins Bexion Pharmaceuticals Board

January 6, 2011 4:32 am | by Bio-Medicine.Org | News | Comments

COVINGTON, Ky., Jan. 6, 2011 /- Bexion Pharmaceuticals, LLC announced today that it has added Lester Crawford, D.V.M., and Ph.D. to its Board of Directors. Dr. Crawford has had a distinguished career in the public and private sectors as well as academia. Over ten years of his career were...


OnePartner selects MobileMD for Health Information Exchange

January 6, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

DUFFIELD, Va. and WARMINSTER, Pa., Jan. 6, 2011 /- OnePartner, LLC selects MobileMD, Inc. for Health Information Exchange (HIE) component of innovative, cost effective, and rapidly deployed Electronic Health Record (EHR) solution. Leveraging popular cloud computing techniques designed...


Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million

January 6, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., Jan. 6, 2011 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug...


Viveve Obtains CE Mark for Gynecologic Treatment of Vaginal Laxity

January 6, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Jan. 6, 2011 /- Viveve, Inc. , a development stage women's health company, announced today that it has received the European CE (Conformite Europeenne) mark for the use of its Viveve System for the non-surgical treatment of laxity of the vaginal introitus (opening),...


Boston Scientific buys Intelect Medical for $60M

January 6, 2011 3:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Boston Scientific Corp. has acquired Intelect Medical Inc., a Boston-based company that recently moved here from Ohio, and is developing technologies for deep brain stimulation, for $60 million in cash.


IRIDEX to Present at the OneMedForum San Francisco 2011 Conference

January 6, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Jan. 6, 2011 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced that management will present at the OneMedForum San Francisco 2011 Conference at 8:45 a.m. PST on Tuesday, January 11.  The conference will be held on January 11-13 at the Sir Francis Drake...


CeNeRx Initiates Phase II Trial of TriRimaâ„¢ as Monotherapy in Treatment Resistant Depression

January 6, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., Jan. 6, 2011 /- CeNeRx BioPharma, Inc., today reported that it has initiated a Phase II trial of its new formulation of TriRima ™, the company's novel antidepressant in development as monotherapy for treatment resistant depression.  CeNeRx also...


Vapotherm, Inc. Announces CE Mark Approval for Flowrest® Homecare Device

January 6, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

STEVENSVILLE, Md., Jan. 6, 2011 /PRNewswire-USNewswire/ -- Vapotherm, the global leader in High Flow Therapy products, announced receiving CE marking for Flowrest®, a device designed for homecare and other low acuity environments. The Flowrest® device delivers warmed humidified...


Sun Healthcare sets 2011 guidance

January 6, 2011 2:45 am | by The Associated Press | News | Comments

Health care facility operator Sun Healthcare Group Inc. said Thursday it expects earnings of between $1.30 and $1.45 per share in 2011, while expanding capacity.The company based in Irvine, Calif., also expects revenue between $1.95 billion and $2 billion.Analysts polled by Thomson Reuters expect...

Okla. inmate to be executed for 1995 murder

January 5, 2011 11:45 pm | by TIM TALLEY - Associated Press - Associated Press | News | Comments

An Oklahoma death row inmate convicted of the baseball-beating death of a convenience store work almost 16 years ago is scheduled to become the first person executed in the U.S. this year.Billy Don Alverson, 39, was convicted of first-degree murder and sentenced to die for the Feb, 26, 1995,...

Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range

January 5, 2011 11:34 pm | by Bio-Medicine.Org | News | Comments

BEIJING, Jan. 6, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading provider of biopharmaceutical products in China, announced today its preliminary unaudited sales range for the fourth quarter and full year ended December 31, 2010. A conference call to discuss these...


Jackson Laboratory and Tufts University announce new Ph.D. track in mammalian genetics

January 5, 2011 7:36 pm | by EurekAlert | News | Comments

(Tufts University, Health Sciences) The Jackson Laboratory, Sackler School of Graduate Biomedical Sciences at Tufts and Tufts University School of Medicine announce a new track for Ph.D. students in mammalian genetics. The joint track offers students in-depth research and training...


Nanocarriers Come Through

January 5, 2011 7:35 pm | by Massachusetts Institute of Technology | News | Comments

Tiny Trojan horses deliver a cancer drug to cell nuclei.

Covidien Announces the Availability of Nellcor(TM) OxiMax(TM) SpO2 Technology with Dräger Infinity(R) Acute Care Systemin Europe

January 5, 2011 4:33 pm | by Covidien | News | Comments

BOULDER, Colo., Jan 05, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today announced the availability of the new Infinity(R) MCable(R) with Nellcor(TM)...


Quidel projects 52 percent drop in 4Q revenue

January 5, 2011 2:45 pm | by The Associated Press | News | Comments

Medical diagnostics maker Quidel Corp. said Wednesday it expects to report a 52 percent annual drop in fourth-quarter revenue due to lower sales of influenza products.The company estimates revenue for the three months ended Jan. 2 will total $31.5 million, down from $66.6 million in the...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.